Deva Holding AS
Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and … Read more
Deva Holding AS - Asset Resilience Ratio
Deva Holding AS (DEVA) has an Asset Resilience Ratio of 2.10% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2024)
This chart shows how Deva Holding AS's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Deva Holding AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | TL0.00 | 0% |
| Short-term Investments | TL745.77 Million | 2.1% |
| Total Liquid Assets | TL745.77 Million | 2.10% |
Asset Resilience Insights
- Limited Liquidity: Deva Holding AS maintains only 2.10% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Deva Holding AS Industry Peers by Asset Resilience Ratio
Compare Deva Holding AS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Deva Holding AS (2005–2024)
The table below shows the annual Asset Resilience Ratio data for Deva Holding AS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 4.06% | TL1.21 Billion | TL29.73 Billion | -5.05pp |
| 2023-12-31 | 9.11% | TL2.95 Billion | TL32.40 Billion | +0.59pp |
| 2022-12-31 | 8.52% | TL734.62 Million | TL8.62 Billion | -4.19pp |
| 2019-12-31 | 12.70% | TL269.26 Million | TL2.12 Billion | +12.70pp |
| 2018-12-31 | 0.01% | TL86.10K | TL1.67 Billion | -0.01pp |
| 2008-12-31 | 0.01% | TL73.00K | TL489.79 Million | -0.05pp |
| 2006-12-31 | 0.06% | TL177.00K | TL290.88 Million | +0.05pp |
| 2005-12-31 | 0.01% | TL30.00K | TL273.18 Million | -- |